Benzimidazole-derived ATP analogues as potential glutamine synthetase inhibitors

Synthetic Communications

Volumn 40, Issue 17, 2010, Pages 2578-2587

  Gxoyiya, Babalwa S B ^a   Kaye, Perry T ^a   Kenyon, Colin ^b  

^a RHODES UNIVERSITY   (South Africa)

^b CSIR Bio/Chemtek   (South Africa)

Author keywords

ATP analogues; benzimidazole derivatives; glutamine synthetase inhibitors; phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; ALKYL GROUP; BENZIMIDAZOLE DERIVATIVE; GLUTAMATE AMMONIA LIGASE; GLUTAMINE SYNTHETASE INHIBITOR; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; DRUG SYNTHESIS; PHOSPHORYLATION; QUANTUM YIELD; REACTION ANALYSIS;

EID: 77955457731     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910903289263     Document Type: Article

References (24)

1. Zhang, Y.; Amzel, L. M. Tuberculosis drug targets. Curr. Drug Targets 2002, 3, 131-154.
2. World Health Organization. Emergence of XDR-TB. Available at http://www.who.int/mediacentre/news/notes/2006/np23/en/print.html
3. Waksman, S. A.; Henrici, A. T. The nomenclature and classification of the actinomycetes. J. Bact. 1943, 46, 337-341.
4. Fox, H. H. Chemical approach to the control of tuberculosis. Science (New York) 1952, 116, 129-135.
5. Bernstein, J.; Lott, W. A.; Steinberg, B. A.; Yale, Harry L. Chemotherapy of experimental tuberculosis, V: Isonicotinic acid hydrazide (Nydrazid) and related compounds. Am. Rev. Tuberc. 1952, 65, 357-364.
6. Steenken Jr., W.; Wolinsky, E. Antituberculous properties of hydrazines of isonicotinic acid (rimifon, marsilid). Am. Rev. Tuberc. 1952, 65, 365-375.
7. Yeager, R. L.; Munroe, W. G. C; Dessau, F. I. Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis. Am. Rev. Tuberc. 1952, 65, 523-534.
8. Aquinas, M. Short-course therapy for tuberculosis. Drugs 1982, 24(2), 118-132.
9. Frieden, T. R.; Sterling, T. R.; Munsiff, S. S.; Watt, C. J.; Dye, C. Tuberculosis. Lancet 2003, 362, 887-899.
10. Kuehl Jr., F. A.; Wolf, F. J.; Trenner, N. R.; Peck, R. L.; Buhs, R. P.; Putter, I.; Ormond, R.; Lyons, J. E.; Chaiet, L.; Howe, E.; Hunnewell, B. D.; Downing, G.; Newstead, E.; Folkers, K. D-4-Amino-3-isoxazolidinone, a new antibiotic. J. Am. Chem. Soc. 1955, 77, 2344-2345.
11. De Souza, M. V. N. New fluoroquinolones: A class of potent antibiotics. Rev. Med. Chem. 2005, 5, 1009-1017.
12. Cole, S. T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C; Harris, D.; Gordon, S. V.; Eiglmeier, K.; Gas, S.; Barry III, C. E.; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.-A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J. E.; Taylor, K.; Whitehead, S.; Barrell, B. G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393, 537-544.
13. Gill, H. S.; Eisenberg, D. The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry 2001, 40, 1903-1912.
14. Harth, G.; Horwitz, M. A. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets. J. Exp. Med. 1999, 189, 1425-1435.
15. Cook, G. C. Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy. Parasitol. Today 1990, 6, 113-136.
16. Tan, K. L.; Vasudevan, A.; Bergman, R. G.; Ellman, J. A.; Souers, A. J. Microwave-assisted C H bond activation: A rapid entry into functionalized heterocycles. Org. Lett. 2003, 5, 2131-2134.
17. Fessenden, R. J.; Fessenden, J. S. Techniques and Experiments for Organic Chemistry; Willard Grant Press: Boston, 1983; pp. 248-251.
18. Bhushan, V.; Rathore, R.; Chandrasekaran, S. A simple and mild method for the cis-hydroxylation of alkenes with cetyltrimethylammonium permanganate. Synthesis 1984, 431-433.
19. Kanayama, T.; Yoshida, K.; Miyabe, H.; Kimachi, T.; Takemoto, Y. Synthesis of b-substituted a-amino acids with use of iridium-catalyzed asymmetric allylic substitution. J. Org. Chem. 2003, 68, 6197-6201.
20. Petrushkina, E. A.; Gavrilenko, V. V.; Oprunenko, Y. F.; Akhmedov, N. G. Control of the regioselectivity of isoprene telomerization with benzimidazole catalyzed by palladium complexes. Akhmedov, Zh. Obshch. Khim. 1996, 66, 1864-1870; CAN 126:144225.
21. Marasco Jr., C. J.; Piantadosi, C.; Meyer, K. L.; Morris-Natschke, S.; Ishaq, K. S.; Small, G. W.; Daniel, L. W. Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C. J. Med. Chem. 1990, 33, 985-992.
22. Robins, M. J.; Hatfield, P. W. Nucleic acid related compounds, 37: Convenient and high-yield syntheses of N-[(2-hydroxyethoxy)methyl]heterocycles as "acyclic nucleoside" analogs. Can. J. Chem. 1982, 60, 547-553.
23. Yavorskii, A. E.; Stetsenko, A. V.; Gogoman, I. V.; Boiko, V. N.; Zavgorodnii, S. G.; Sobko, A. I.; Tatskaya, V. N.; Kvachev, V. G.; Florent'ev, V. L. Acyclic analogs of nucleosides: Synthesis of hydroxyalkyl derivatives of 2-trifluoromethyl-and 2-(trifluoro-methylthio)benzimidazoles. Khim. Geterotsikl. Soedin. 1988, 2, 198-202; CAN 110:114751.
24. Garuti, L.; Ferranti, A.; Giovanninetti, G.; Scapini, G.; Franchi, L.; Landini, M. P. Studies on potential antiviral compounds, XXII: Synthesis and in vitro antiviral activity of 1-(hydroxyalkyl)-1H-benzimidazoles. Arch. Pharm. 1982, 315, 1007-1013.